$8.32
-0.18%LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, the company offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. LifeVantage Corporation is headquartered in Lehi, Utah.
Chief Digital Officer
Chief Financial Officer
Compensation
$382,583
Chief Information & Innovation Officer
Chief Marketing Officer
Compensation
$346,489
Chief People Officer
Compensation
$242,092
Chief Sales Officer
General Counsel & Corporate Secretary
Compensation
$362,649
President, Chief Executive Officer & Director
Compensation
$655,146
During the last 12 months, insiders have purchased $613K and sold $745K worth of LFVN shares, resulting in $131K of net selling activity.
1.1K
5.52K
0
0.00
+6K
+$6K
38.0K
178.34K
0
0.00
+178K
+$178K
54.6K
424.88K
62.2K
462.93K
-38K
-$38K
370
4.76K
21.1K
282.05K
-277K
-$277K
Dayton Judd
Director
$152K
Anbalagan Rajendran
Director
$105K
Beindorff Michael A
Director
$105K
Latham Cynthia
Director
$105K
Greer Raymond B
Director
$105K
Fife Steven R
Director, Officer: President And Ceo
$360K
Beindorff Michael A
Director
$325K
Boyster Julie
Officer: Chief Marketing Officer
$18K
Cunningham Kristen
Officer: Chief Sales Officer
$16K
Aure Carl
Officer: Chief Financial Officer
$13K
Slightly bearish with $131K net selling. Selling modestly exceeds buying, which could be routine diversification rather than concern.
Moderately negative ratio. Selling is roughly double the buying, which may be routine or signal caution.
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
5 insider buyers and 5 sellers. Equal participation suggests mixed or neutral insider views.
LFVN - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | September 19, 2025 | September 19, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | September 20, 2024 | September 20, 2024 | 2024 | |
DEF 14A DEF 14A 2022 N/A | September 30, 2022 | September 16, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | September 30, 2021 | September 17, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | September 30, 2020 | September 18, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | October 18, 2019 | October 10, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | September 28, 2018 | September 28, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | December 20, 2017 | December 20, 2017 | 2017 | |
DEF 14A DEF 14A 2017 N/A | January 04, 2017 | January 04, 2017 | 2017 | |
DEF 14A DEF 14A 2015 N/A | September 11, 2015 | October 15, 2015 | 2015 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.